3 minutes read)
- Macro Group for Pharmaceuticals Company (Macro Capital) has started its stock trading under the symbol (MCRO.CA) at the Egyptian Stock Exchange (EGX)
- At a ceremony to mark its entry to the stock exchange , several dignitaries were present including Mohamed Farid Saleh, Chairman of the EGX, and top officials of the company responsible for promotion and offering
- The public and private offering of the Macro Group Company for Pharmaceuticals is 264.5 million shares
Macro Group for Pharmaceuticals Company (Macro Capital) has started its stock trading under the symbol (MCRO.CA) at the Egyptian Stock Exchange (EGX).
At a ceremony to mark its entry to the stock exchange , several dignitaries were present including Mohamed Farid Saleh, Chairman of the EGX, and top officials of the company responsible for promotion and offering.
The public and private offering of the Macro Group Company for Pharmaceuticals is 264.5 million shares. This represents 45.8 percent of the company’s issued capital shares. It is priced at LE 4.85 per share and will be offloaded in two tranches (public and private) with a total value of LE 1.3 billion, distributed between LE 1.2 billion in the value of the private offering and LE 64.1 million in the value of the public offering.
The number of offering shares were distributed over public offerings and private placements. Close to 13.2 million shares, representing 5 percent of the total shares offered for public offering which represented 2.3 percent of the total issued shares of the company. The number of private placement shares is 251.3 million. It represents 95 percent of the number of shares offered for sale and 43.5 percent of the company’s total issued shares. The company’s market capital is approximately LE 2.8 billion. About 5,600 investors participated in the public and private offerings, of whom 49.6 percent were new investors who bought about 31 percent of the total offering.
